Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ACORDA THERAPEUTICS INC Analyst Recommendations

  • Analyst Consensus: ACOR

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.917 Buy 12
    30 Days Ago 1.917 Buy 12
    60 Days Ago 1.909 Buy 11
    90 Days Ago 1.909 Buy 11
    120 Days Ago 2.000 Buy 11
  • Analyst Ratings: ACOR

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Merriman Neutral Buy 10/15/2009
    Robert W. Baird Neutral Outperform 10/14/2009 28.00
    Rodman & Renshaw Mkt Perform Mkt Underperform 10/12/2009 5.00
    Merriman Neutral 09/28/2009
    Piper Jaffray Neutral Overweight 08/05/2009
    Leerink Swann Underperform Outperform 07/02/2009 30.00
    Piper Jaffray Buy Neutral 07/01/2009
    Lazard Capital Mkts Buy 03/31/2009 30.00
    Hapoalim Outperform 03/24/2009 35.00
    FTN Equity Capital Buy 03/12/2009
    Lazard Capital Buy 02/24/2009 34.00
    Piper Jaffray Buy 12/16/2008
    Deutsche Securities Buy 11/25/2008
    RBC Capital Mkts Outperform 11/07/2008 30.00
    Robert W. Baird Neutral Outperform 11/03/2008 33.00
    Lazard Capital Buy 07/22/2008 39.00
    Friedman Billings Mkt Perform 07/10/2008
    Friedman Billings Outperform Mkt Perform 06/23/2008 32.00
    Robert W. Baird Neutral 02/21/2008 28.00
    Fortis Bank Buy 01/29/2008 37.00
    Fortis Bank Buy 06/21/2007 33.00
    Banc of America Sec Neutral Buy 06/19/2007 26.00
    Deutsche Securities Buy 04/12/2007 29.00
    Friedman Billings Outperform 04/11/2007 32.00
    Lazard Capital Buy 02/21/2007 28.00
    Morgan Joseph Sell 02/21/2007 15.00
    Banc of America Sec Buy Neutral 02/21/2007 26.00
    Lazard Captial Buy 11/02/2006 24.00
    Banc of America Sec Buy 11/02/2006 24.00
    Piper Jaffray Outperform 10/24/2006 25.00